Cargando…

New developments in systemic lupus erythematosus

In this review, the results of recent and ongoing clinical trials in patients with SLE are discussed. After many unsuccessful trials in the past decade, belimumab was the first biologic specifically designed for SLE that met its primary end point. At the same time, studies on the pathophysiology of...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsang-A-Sjoe, Michel W. P., Bultink, Irene E. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709564/
https://www.ncbi.nlm.nih.gov/pubmed/34951924
http://dx.doi.org/10.1093/rheumatology/keab498

Ejemplares similares